You may want to have a look at this company. MRNS and SAGE have basically the same drug candidate(allopregnanolone , a GABA modulator) and very similar pipeline. MRNS has $27M market cap (lower than cash less debt as of 30/09/2016) whereas SAGE has $2B market cap.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.